NCT00515801View on ClinicalTrials.gov

Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DM

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 30, 2007

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

glibenclamide

glibenclamide 15 mg single dose

DRUG

placebo

placebo capsules, single dose

Trial Locations (1)

4031

University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT00515801 - Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DM | Biotech Hunter | Biotech Hunter